FDA Hits Glenmark for Quality Controls, Complaint Handling

Drug Industry Daily
A A
The FDA cited a Glenmark Pharmaceuticals facility in Solan, India for failing to investigate discrepancies, inadequate complaint records and improper maintenance of quality data.

To View This Article:

Login

Subscribe To Drug Industry Daily